Sahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, Sarah Gholami, Reza Hashemipour, Negin Biavarz, Farnaz Yousefi, Ali Tashakori, Farshid Salmani, Romina Rajabi, Ramin Khorrami, Noushin Nabavi, Jun Ren, Shokooh Salimimoghadam, Mohsen Rashidi, Mohammad Arad Zandieh, Kiavash Hushmandi, Yuzhuo Wang
In addition to environmental conditions, lifestyle factors, and chemical exposure, aberrant gene expression and mutations involve in the beginning and development of urological tumors. Even in Western nations, urological malignancies are among the top causes of patient death, and their prevalence appears to be gender dependent. The prognosis for individuals with urological malignancies remains dismal and unfavorable due to the ineffectiveness of conventional treatment methods. PI3K/Akt is a popular biochemical mechanism that is activated in tumor cells as a result of PTEN loss...
July 23, 2023: European Journal of Pharmacology